Survival Analysis in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Chemoradiotherapy Followed by Surgery According to the International Consensus on the 2017 Definition of Borderline Resectable Cancer

International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017

(2018) Shuji Isaji et al.   PANCREATOLOGY

Evaluation and proposal of novel resectability criteria for pancreatic cancer established by the Japan Pancreas Society

(2017) Suguru Yamada et al.   SURGERY

Pancreatic Adenocarcinoma, Version 2.2012

(2017) Margaret A. Tempero et al.   Journal of the National Comprehensive Cancer Network

The Significance of the Prognostic Nutritional Index for All Stages of Pancreatic Cancer

(2016) Sang Hoon Lee et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

Human Equilibrative Nucleoside Transporter 1 Expression in Endoscopic Ultrasonography-Guided Fine-Needle Aspiration Biopsy Samples Is a Strong Predictor of Clinical Response and Survival in the Patients With Pancreatic Ductal Adenocarcinoma Undergoing Gemcitabine-Based Chemoradiotherapy

(2016) Reiko Yamada et al.   PANCREAS

SMAD4 Expression Predicts Local Spread and Treatment Failure in Resected Pancreatic Cancer

(2015) Suguru Yamada et al.   PANCREAS

Host systemic inflammatory response influences outcome in pancreatic cancer

(2015) Clem W. Imrie   PANCREATOLOGY

Anterior Approach to the Superior Mesenteric Artery by Using Nerve Plexus Hanging Maneuver for Borderline Resectable Pancreatic Head Carcinoma

(2014) Shugo Mizuno et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Gemcitabine-Based Chemoradiotherapy Followed by Surgery for Borderline Resectable and Locally Unresectable Pancreatic Ductal Adenocarcinoma

(2014) Motoyuki Kobayashi et al.   PANCREAS

Selection criteria in resectable pancreatic cancer: A biological and morphological approach

(2014) Domenico Tamburrino   WORLD JOURNAL OF GASTROENTEROLOGY

Borderline Resectable Pancreatic Cancer: Need for Standardization and Methods for Optimal Clinical Trial Design

(2013) Matthew H. G. Katz et al.   ANNALS OF SURGICAL ONCOLOGY

Radiographic Tumor–Vein Interface as a Predictor of Intraoperative, Pathologic, and Oncologic Outcomes in Resectable and Borderline Resectable Pancreatic Cancer

(2013) Hop S. Tran Cao et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Morbidity and Mortality after Pancreaticoduodenectomy in Patients with Borderline Resectable Type C Clinical Classification

(2013) Ching-Wei D. Tzeng et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Clinical features and treatment outcome of borderline resectable pancreatic head/body cancer: a multi-institutional survey by the Japanese Society of Pancreatic Surgery

(2013) Hiroyuki Kato et al.   Journal of Hepato-Biliary-Pancreatic Sciences

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

(2013) Daniel D. Von Hoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

CA19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Perioperative Therapy

(2012) Werner Hartwig et al.   ANNALS OF SURGICAL ONCOLOGY

Performance status of patients is the major prognostic factor at all stages of pancreatic cancer

(2012) Faruk Tas et al.   International Journal of Clinical Oncology

Human equilibrative nucleoside transporter 1 expression is a strong independent prognostic factor in UICC T3-T4 pancreatic cancer patients treated with preoperative gemcitabine-based chemoradiotherapy

(2011) Yasuhiro Murata et al.   Journal of Hepato-Biliary-Pancreatic Sciences

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

(2011) Thierry Conroy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impact of Histological Response After Neoadjuvant Chemoradiotherapy on Recurrence-Free Survival in UICC-T3 Pancreatic Adenocarcinoma But Not in UICC-T4

(2011) Yasuhiro Murata et al.   PANCREAS

The Clavien-Dindo Classification of Surgical Complications

(2009) Pierre A. Clavien et al.   ANNALS OF SURGERY

Resectable Pancreatic Cancer: Who Really Benefits From Resection?

(2009) Giuliano Barugola et al.   ANNALS OF SURGICAL ONCOLOGY

Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease

(2008) Matthew H.G. Katz et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS